Last update 07 Jun 2025

SYHA1801

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SYHA 1801, SYHA-1801
Target
BRD4
Action
inhibitors
Mechanism
BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Advanced Malignant Solid Neoplasm
Originator Organization
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
Active Organization-
Inactive Organization
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with SYHA1801
NCT04309968
/ Unknown statusPhase 1
A Phase I Clinical Trial Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Anti-tumor Activity of SYHA1801 Capsules in Patients With Advanced Solid Tumors.
100 Clinical Results associated with SYHA1801
Login to view more data
100 Translational Medicine associated with SYHA1801
Login to view more data
100 Patents (Medical) associated with SYHA1801
Login to view more data
100 Deals associated with SYHA1801
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co., Ltd.
07 Apr 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free